86.21.Z - General medical practice activities
68.10.Z - Buying and selling of own real estate
68.20.Z - Rental and operating of own or leased real estate
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.22.Z - Specialist medical practice activities
86.90.A - Physiotherapeutical activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2,2 | 0,6 | 1,3 | 122,8 |
EBITDA | 2,3 | 1 | 1,8 | 75 |
Short time liabilities | 0,8 | 0,7 | 1,2 | 71,4 |
Equity capital | 1,9 | 2,5 | 3,8 | 51,5 |
Operating profit (EBIT) | 2,2 | 0,8 | 1,6 | 92,3 |
Assets | 2,8 | 6,2 | 7,8 | 25,8 |
Net profit (loss) | 2 | 0,6 | 1,3 | 123,8 |
Cash | 0,8 | 0,6 | 1,3 | 96 |
Net income from sale | 7,1 | 7,5 | 9,5 | 27,4 |
Liabilities and provisions for liabilities | 0,9 | 3,7 | 4 | 8,3 |
Working assets | 2,8 | 1,5 | 2,6 | 72,9 |
Depreciation | 0,1 | 0,2 | 0,2 | 3,7 |
% | % | % | p.p. | |
Profitability of capital | 104,4 | 23 | 34 | 11 |
Equity capital to total assets | 69,3 | 40,6 | 48,8 | 8,2 |
Gross profit margin | 31,3 | 7,8 | 13,7 | 5,9 |
EBITDA Margin | 32,8 | 14 | 19,2 | 5,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 41 | 34 | 46 | 12 |
Current financial liquidity indicator | 3.2018117904663086 | 2.0133135318756104 | 2.1285512447357178 | 0,1 |
Net dept to EBITDA | -0.33458900451660156 | 2.455700635910034 | 0.9895753264427185 | -1,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane